Nav: Home

The importance of the glutamine metabolism in colon cancer

January 10, 2017

The importance of glutamine metabolism for colon cancer was revealed by Masamitsu Konno, Ph.D, Masaaki Miyo, M.D. Ph.D, Masaki Mori, M.D. Ph.D and Hideshi Ishii, M.D. Ph.D. The aim of this study is to elucidate metabolic adaptation to nutritional stress and the role of the involved oncogenes in human colorectal cancer. The present study showed that the metabolism of colorectal cancer, distinct from that of pancreatic cancer, depended on genomic alterations, which previously have been uncharacterized, and was not restricted to KRAS mutation alone. Colorectal cancer can survive under the condition of glucose depletion while retaining TCA cycle activity. The cells' survival relies on a delicate balance between energy and reactive oxygen species (ROS) production. Glutamate dehydrogenase 1 (GLUD1) and SLC25A13 have pivotal roles under glucose-deprived conditions and are associated with tumor aggressiveness and colorectal cancer prognosis.

GLUD1 and SLC25A13 have pivotal roles in nutritional stress and are associated with tumor aggressiveness and poorer prognosis of colorectal cancer. These proteins may serve as new targets in the treatment of refractory colorectal cancer.

"We found that colorectal cancer cells survived under the condition of glucose depletion, and their resistance to such conditions depended on genomic alterations rather than on KRAS mutation alone. Metabolomic analysis demonstrated that those cells maintained TCA cycle activity and ATP production under such conditions. Furthermore, we identified pivotal roles of GLUD1 and SLC25A13 in nutritional stress. GLUD1 and SLC25A13 were associated with tumor aggressiveness and poorer prognosis of colorectal cancer. ", says Hideshi Ishii. "GLUD1 and SLC25A13 may serve as new targets in treating refractory colorectal cancer, which survives in malnutritional microenvironments."
-end-


Osaka University

Related Colorectal Cancer Articles:

New method for early screening of colorectal cancer
A highly sensitive method that can detect even the earlier stages of colorectal cancer has been developed by researchers in Japan.
Adults with disabilities screened less often for colorectal cancer
Colorectal cancer is the fourth most common type of cancer in the United States, with nearly 135,000 cases reported in 2016.
Colorectal cancer statistics, 2017
Despite dramatic reductions in overall colorectal cancer incidence and mortality, striking disparities by age, race, and tumor subsite remain
Gene mutations among young patients with colorectal cancer
While many patients with colorectal are diagnosed when they are older than 50, about 10 percent of patients are diagnosed at younger ages.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
New immunotherapy study at Sanford centers on colorectal cancer
Sanford Health has opened another clinical trial exploring the power of the body's immune system to fight cancer.
UA Cancer Center team questions safety, efficacy of selenium and colorectal cancer risk
Selenium has been a popular nutritional supplement for decades, touted for its antioxidant properties and its role in stopping free radicals from damaging cells and DNA.
How mouth microbes may worsen colorectal cancer
Bacteria commonly found in the mouth have been recently shown to worsen colorectal cancer in animals, but it has not been clear how these microbes make their way to the gut in the first place.
Pretargeted radioimmunotherapy may eliminate colorectal cancer
An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models.
As colorectal cancer rate falls, diagnosis of late-stage cancer in young patients is up
University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2016 finds that in patients over 50, the rate of CRC is falling at 2.5 percent per year while the rate of CRC in patients under 50 is rising at 0.8 percent per year.

Related Colorectal Cancer Reading:

American Cancer Society's Complete Guide to Colorectal Caner
by American Cancer Society (Author)

Don't die of embarrassment--get informed about colorectal cancer

Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete Guide to Colorectal Cancer provides sound information and support if you are concerned about or diagnosed with colorectal cancer.

Written by experts in oncology,... View Details


Be a Survivor - Colorectal Cancer Treatment Guide
by Vladimir Lange (Author)

This much-needed colorectal cancer resource is developed in consultation with a large national team of experts and endorsed not only by the American Society of Colon and Rectal Surgeons but also by the National non-profit the Colon Cancer Alliance. As with all of the Be a Survivor resources this book features candid testimonials by survivors. It is straightforward, easy-to-understand and contains objective and up-to-date information. The beautiful color photos and graphics enhance the learning process. Most importantly the book leaves the reader with a message of hope. The book addresses each... View Details


The Colorectal Cancer Survival Guide
by Robert Sieben MD (Author)

After receiving medical treatments for colorectal cancer, Robert Sieben, MD, was left on his own to find ways of dealing with the devastating complications. Now, twenty years out, he shares his experience. Empowered by his medical training and his intense desire to make the most of his life, Sieben developed a range of innovative strategies to manage the socially debilitating symptoms, including urgency and incontinence of both rectal and urinary functions. Offering hope to the 25 million Americans who suffer similar symptoms from a variety of causes, Beyond Survival describes the... View Details


Multidisciplinary Treatment of Colorectal Cancer: Staging – Treatment – Pathology – Palliation
by Gunnar Baatrup (Editor)

This book is intended as the equivalent of the Swiss Army knife for all members of colorectal cancer (CRC) multidisciplinary teams and those training in the fields of CRC management. It describes how to organize the team and explains the basic principles within the different disciplines involved in the treatment and care of CRC patients. Important, up-to-date knowledge is provided on visualization techniques, surgery, oncological treatment, palliation, and pathology, with special focus on controversies and aspects of interest to all team members. Care has been taken to ensure that each... View Details


Johns Hopkins Patient Guide to Colon and Rectal Cancer (Johns Hopkins Patients' Guide)
by Nita Ahuja (Author)

Johns Hopkins Patient Guide to Colon and Rectal Cancer is a concise patient guide on treating and coping with colorectal cancer.

About the Series:
Learning that you or someone you love has cancer is devastating, and feeling lost and powerless is a common immediate response. The Johns Hopkins Patients' Guides are designed to alleviate your anxiety, empower you with information, and enable you to fully understand your treatment options. Each book in this series is dedicated to a specific type of cancer. The information is there to help lighten your burden and to assist you in becoming... View Details


Colorectal Cancer (Oxford Oncology Library)
by Daniel Swinson (Author), Matthew Seymour (Author)

Colorectal cancer is one of the leading causes of cancer-related death in the world. Twenty-five percent of patients present with advanced disease and, despite complete surgical resection of early stage disease, 50% of patients relapse. The treatment of colorectal cancer has advanced rapidly in recent years, and controversies persist regarding optimal management (e.g. whether combination chemotherapy should be used first-line or in a staged fashion, how long to treat patients for and whether to use an intermittent or continuous schedule and whether to refer for a radical approach for advanced... View Details


Medifocus Guidebook on: Colorectal Cancer
by Medifocus.com (Author), Elliot Jacob PhD. (Editor)

The MediFocus Guidebook on Colorectal Cancer is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Colorectal Cancer, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Colorectal Cancer, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert... View Details


Positive Options for Colorectal Cancer: Self-Help and Treatment
by Carol Ann Larson (Author), Kathleen Ogle M.D. (Foreword)

Did you know:
* Approximately 80-90 million Americans are considered at risk for developing colorectal cancer
* More than 147,000 new cases of colorectal cancer will be diagnosed this year in the US.
* Colorectal cancer is the second leading cancer killer of adults in America, and the 4th most commonly diagnosed cancer
* Although the majority of people diagnosed with colorectal cancer are over 50, it can strike people of any age, any race

Written by one of the founding members of Advocates for Colorectal Education, (ACE), this book contains everything you need to know about... View Details


Cancer Family: The Search for the Cause of Hereditary Colorectal Cancer
by C. Richard Boland MD (Author)

It is 1946, and a young man stares out his third-story apartment window. He has returned from the war with metastatic cancer and assumes he will die, leaving his wife and infant daughter behind. Instead, he lives another twenty-four years, raising a family of four children, before he succumbs to a second colon cancer. His son, the author, recognizes that there is a hereditary cancer syndrome in the family and resolves to solve the problem as a medical researcher. Eventually, hereditary colorectal cancer is recognized as a medical entity, and multiple genes responsible for this hereditary... View Details


Positive Options for Colorectal Cancer, Second Edition: Self-Help and Treatment (Positive Options for Health)
by Carol Ann Larson (Author), Kathleen Ogle M.D. (Foreword)

Positive Options for Colorectal Cancer offers readers everything they need to know about understanding and dealing with colorectal cancer. It presents detailed information in a clear and concise manner from a well-known advocate and author who is a personal survivor of Stage III colorectal cancer for more than 20 years. Chapters present information on prevention techniques, warning signs, and screening tests including the latest on virtual colonoscopy and how to find and talk honestly with the right doctor. It offers tips on treatment options including surgery, chemotherapy, radiation... View Details

Best Science Podcasts 2017

We have hand picked the best science podcasts for 2017. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Simple Solutions
Sometimes, the best solutions to complex problems are simple. But simple doesn't always mean easy. This hour, TED speakers describe the innovation and hard work that goes into achieving simplicity. Guests include designer Mileha Soneji, chef Sam Kass, sleep researcher Wendy Troxel, public health advocate Myriam Sidibe, and engineer Amos Winter.
Now Playing: Science for the People

#448 Pavlov (Rebroadcast)
This week, we're learning about the life and work of a groundbreaking physiologist whose work on learning and instinct is familiar worldwide, and almost universally misunderstood. We'll spend the hour with Daniel Todes, Ph.D, Professor of History of Medicine at The Johns Hopkins University, discussing his book "Ivan Pavlov: A Russian Life in Science."